---
title: "Omega-3-Carboxylic Acids - Hypertriglyceridemia"
sidebar: mydoc_sidebar
permalink: db09568-mesh-d015228-1.html
toc: false 
---


Path ID: `DB09568_MESH_D015228_1`
{% include image.html url="images/db09568-mesh-d015228-1.png" file="db09568-mesh-d015228-1.png" alt="db09568-mesh-d015228-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/DB:DB09568">DB:DB09568 </a> | omega-3-carboxylic acids | Drug |
| <a href="https://identifiers.org/UniProt:O75907">UniProt:O75907 </a> | Diglyceride acyltransferase | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-75109">reactome:R-HSA-75109 </a> | Triglyceride biosynthesis | Pathway |
| <a href="https://identifiers.org/GO:0006635">GO:0006635 </a> | Fatty acid beta-oxidation | BiologicalProcess |
| <a href="https://identifiers.org/UBERON:0000178">UBERON:0000178 </a> | Blood | GrossAnatomicalStructure |
| <a href="https://identifiers.org/UniProt:P06858">UniProt:P06858 </a> | Lipoprotein lipase | Protein |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglyceride | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D015228">MESH:D015228 </a> | Hypertriglyceridemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Omega-3-Carboxylic Acids | DECREASES ACTIVITY OF | Diglyceride Acyltransferase |
| Diglyceride Acyltransferase | NEGATIVELY REGULATES | Triglyceride Biosynthesis |
| Triglyceride Biosynthesis | DECREASES ABUNDANCE OF | Triglyceride |
| Omega-3-Carboxylic Acids | INCREASES ACTIVITY OF | Lipoprotein Lipase |
| Lipoprotein Lipase | LOCATED IN | Blood |
| Blood | INCREASES DEGRADATION OF | Triglyceride |
| Omega-3-Carboxylic Acids | INCREASES ACTIVITY OF | Fatty Acid Beta-Oxidation |
| Fatty Acid Beta-Oxidation | INCREASES DEGRADATION OF | Triglyceride |
| Triglyceride | MANIFESTATION OF | Hypertriglyceridemia |
|---------|-----------|---------|

Comment: The main components of OM3-CA, eicosapentaenoic acid, and docosahexaenoic acid, are poor substrates for the enzymes responsible for the synthesis of triglycerides (TG). It enhances the clearance of TG from circulating VLDL particles; increased breakdown of fatty acids; inhibition of DAG; and increased activity of lipoprotein lipase in blood.

Reference: 
  - [https://go.drugbank.com/drugs/DB09568#mechanismofaction](https://go.drugbank.com/drugs/DB09568#mechanismofaction)
  - [https://en.wikipedia.org/wiki/Omega-3_carboxylic_acids](https://en.wikipedia.org/wiki/Omega-3_carboxylic_acids)
  - [https://pubmed.ncbi.nlm.nih.gov/28003756/](https://pubmed.ncbi.nlm.nih.gov/28003756/)
